- Cited — Sandoz Limited v Bristol-Myers Squibb Holdings Ireland Unlimited Company 2023-05-04
“…In Warner-Lambert Co LLC v Generics (UK) Ltd [2018] UKSC 56, [2019] Bus LR 360 the patent contained second medical use claims in Swiss form of a known pharmaceutical, pregabalin. Claim 1 claimed the use of pregabalin to treat pain. Claim …”
- Cited — Dr Reddy's Laboratories (UK) Limited & Ors v Warner-Lambert Company LLC 2023-02-01
“…o argue the infringement issues. On 14 November 2018 the Supreme Court handed down judgment dismissing the appeal and allowing the cross-appeal [2018] UKSC 56, [2019] Bus LR 360 (“Warner-Lambert SC”). In brief summary, the majority of the Supreme Court agreed with the lower courts that claims 1 and 3 (and therefore claims 4, 6, 13 and …”
- Cited — Alcon Research LLC & Anor. v Pharmathen SA & Anor. 2022-06-28
“…[2018] UKSC 56, [2019] Bus LR 360 at [36]: “the specification must disclose some reason for supposing that the implied assertion of efficacy in the claim is true”.…”
- Followed — Neurim Pharmaceuticals (1991) Limited & Anor. v Generics (UK) Limited & Anor. 2022-05-27
“…[2018] UKSC 56, [2019] Bus LR 360 at [36]-[37] as follows:…”
- Cited — Illumina Cambridge Limited v Latvia MGI Tech Sia 2021-12-17
“…e that, if plausibility is required, the criterion for plausibility is that stated by Lord Sumption in Warner-Lambert Co LLC v Generics (UK) Ltd[2018] UKSC 56, [2019] Bus LR 360 at [36]: “the specification must disclose some reason for supposing that the implied assertion of efficacy in the claim is true”. As Lord Sumption went on to e…”
- Cited — L'Oreal (UK) Ltd & Anor v Liqwd Inc & Anor 2019-11-18
“…Before us counsel for Olaplex placed some reliance upon the line of cases culminating in Generics (UK) Ltd v Warner-Lambert Co LLC [2018] UKSC 56, [2019] Bus LR 360 in which courts have rejected applications made by patentees to amend the claims of patents after trial on the ground of abuse of process. It should be noted t…”